Friday, July 31, 2026

BLACKPINK’s Jennie Sparks Romance Rumors with Taiwanese Model Kai in New Music Video

BLACKPINK's Jennie shares a sweet video with model Kai, showcasing their chemistry ahead of her new single "Less than a Lover."

Is This the End for Park Sang-yong? Legal Battle Looms Over North Korean Remittance Case

Prosecutor Park Sang-yong is suspended amid allegations of coercion in the North Korea remittance case, claiming political motivations behind the action.

TREASON IN SEOUL: Activists Jailed For Saving North Korean Lives While The Government Sits SILENT

North Korea-focused group members face prosecution for launching balloons with anti-regime propaganda, violating safety laws.

Tag: trial

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

JP-2266: The Next-Gen Diabetes Treatment Revolutionizing Blood Sugar Control in Asia

Jeil Pharmaceutical's JP-2266 shows significant blood sugar improvement in phase II trials, with benefits in weight loss and cardiovascular health.

AriBio Completes Global Phase 3 Trial of Alzheimer’s Drug AR1001, Awaits Topline Results

AriBio completes final patient follow-up in Phase 3 trial for Alzheimer's treatment AR1001, entering data analysis phase.

Kolon Group’s Biotech Bet Faces Uncertainty as October Trial Readout Becomes Critical

Kolon TissueGene's TG-C osteoarthritis treatment failed its first U.S. Phase 3 trial, raising doubts about the biotech's future.

Kolon TissueGene Says TG-C Fails to Meet Statistical Significance in First Phase 3 Trial Analysis in U.S.

Kolon TissueGene's Phase 3 trial for TG-C showed pain relief but lacked statistical significance compared to placebo; further analysis underway.

Belvarafenib: The Promising New Targeted Cancer Drug for NRAS Mutant Melanoma

Hanmi Pharmaceutical presents Belvarafenib's phase 2 trial for NRAS mutant melanoma at KCA 2026, targeting unmet medical needs.

L&K Biomed’s BlueX-C: First Clinical Success in the U.S. Spine Implant Market!

L&K Biomed's BlueX-C cervical cage achieves FDA approval and successful clinical application, signaling strong market potential in the U.S.

Bukwang Pharmaceutical builds turnaround momentum, eyes Parkinson’s drug progress in second half

Bukwang Pharmaceutical is advancing its Parkinson’s treatment CP-012 into a global Phase 2 trial while enhancing RNA technology and manufacturing.

ABL Bio to Launch Global Phase 3 Trial of Gastric Cancer Drug Givastomig This Year at BIO USA

ABL Bio plans a Phase 3 trial for gastric cancer therapy Givastomig, targeting a $2.5 billion market opportunity.

New Hope for IPF Patients: How Jascayd is Revolutionizing Treatment in 2026

Jascayd offers new hope for idiopathic pulmonary fibrosis patients, slowing lung function decline with a novel mechanism of action.

Hyundai Bioscience’s Xafty Clears Genotoxicity Study, Supporting U.S. Phase 2 Respiratory Virus Trial Plans

Hyundai Bioscience's Xafty shows no genotoxicity in tests, aiding its Phase 2 trial plans for respiratory viral infections.

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

DA-2811 vs. Farxiga: Which Diabetes Treatment Proves More Effective in 2026?

Dong-A ST's DA-2811 shows comparable efficacy to Farxiga in diabetes treatment, with positive clinical trial results presented at ADA.

ABL Bio to Showcase Dual-Target ADC Candidate ABL209 at World ADC Korea 2026

ABL Bio will showcase its dual-target ADC candidate ABL209 at the World ADC Korea 2026, focusing on enhanced cancer treatment.

Bukwang Pharma Wins Phase 3 Approval to Expand Latuda Into Adjunctive Treatment for Major Depression

Bukwang Pharmaceutical received approval for a Phase 3 clinical trial of Lurasidone as an adjunctive treatment for MDD.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.